Current through Register Vol. 48, No. 12, March 22, 2024
An assessment shall be conducted prior to admission to any
level of care. This assessment shall be an individual face-to-face service and
shall include collection of demographic data as referenced in Section
2060.325(1)
of this Part and:
a) For admission to
Level 0.5, Early Intervention:
1) review of
any specific conditions of court supervision or probation including any prior
substance abuse screenings or evaluations conducted prior to admission (i.e.,
DUI); and
2) sufficient assessment
to screen for, or rule out, substance related disorders.
b) For admission to Levels I-IV care:
1) an evaluation of the severity of the six
dimensions established in the ASAM Patient Placement Criteria;
2) a recommendation for placement in Levels
I-IV care as established in the ASAM Patient Placement Criteria;
3) a diagnostic impression of substance abuse
and/or dependence as defined in the Diagnostic and Statistical Manual of Mental
Disorders (DSM-IV) that shall be confirmed as a diagnosis by a
physician.
c) Physician
confirmation of diagnosis and initial patient placement:
1) the medical director shall define
protocols and authorize procedures for confirmation of diagnosis or admission
without diagnosis as specified in Section
2060.403(a)
of this Part and initial patient placement in Levels I-IV care.
2) confirmation of diagnosis may be made by
telephone or facsimile transmission if so authorized by procedure.
3) confirmation shall occur no later than 24
hours after admission for Level IV care, no later than 72 hours after admission
for Level III care, and no later than 7 working days after admission for Level
I and II care.
4) confirmation of
diagnosis and admission is not necessary for Level 0.5 Early
Intervention.
d) Prior
to admission, or in the case of an intoxicated patient, as soon as
stabilization occurs, basic information about treatment services shall also be
provided and shall include the following:
1)
the procedures and treatment services the patient will receive;
2) if possible, an introduction to the
professional staff members who serve as the primary contact with the facility
for the client;
3) the hours during
which services are available;
4)
the risks, side effects, and benefits of all medications prescribed by the
organization's medical director or physicians working under his/her supervision
or direction and experimental treatment procedures to be used;
5) the cost, itemized when possible, of
services to be rendered;
6) any
limitations placed on duration of services; and
7) the rules and regulations of the facility
applicable to the patient's conduct.
e) A written, dated, and signed informed
consent form shall be obtained from the patient, or the patient's legal
guardian, and from family members who also participate, for use or performance
of the following activities:
1) experimental
medications;
2) hazardous on
experimental assessment procedures;
3) recording on audiovisual
equipment;
4) participation of the
patient in research projects; and
5) testing for Human Immunodeficiency Virus
(HIV).